Fundraising FoxCleave Biosciences
Burlingame, US · Delaware corporation · 8 known investors
Find your way into Cleave Biosciences
Sign up to see every warm intro you have to Cleave Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cleave Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Board
Investors · 8
How we know: funding news · Not right? Tell us
How we know: funding news · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Nextech Invest's portfolio page · board seat on SEC Form D · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: oup.vc · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$37.9M disclosed across 2 of 3 rounds · 2016–2025
▶$12MraisedJun 2019 · 11 investors · BiotechnologyRule 506(b)
- Amy BurroughsExecutive Officer, Director
- Laura ShawverDirector
- Jonathan RootDirector
- Andrew SchwabDirector
- Peter ThompsonDirector
- Offering amount
- $20.8M
- Amount sold
- $12M
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$26MraisedAug 2016 · 13 investors · BiotechnologyRule 506(b)
- Alfred ScheideggerDirector
- Mark RolfeExecutive Officer
- Peter ThompsonDirector
- Laura ShawverExecutive Officer, Director
- Lewis ShusterDirector
- Carol GallagherDirector
- Jonathan RootDirector
- Timothy SmithExecutive Officer
- Andrew SchwabDirector
- Dennis HennerDirector
- Offering amount
- $36.8M
- Amount sold
- $26M
- First sale
- Jun 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Cleave Biosciences went on to found or lead other companies.
Frequently asked questions
- Who are Cleave Biosciences's investors?
- Cleave Biosciences's investors include Astellas Venture Management LLC, New Enterprise Associates (NEA), Nextech Invest, OUP (Osage University Partners), 5AM Ventures, Clarus Ventures, OrbiMed, US Venture Partners.
- How much funding has Cleave Biosciences raised?
- Cleave Biosciences has disclosed $37.9M raised across 2 of its 3 known rounds.
- Where is Cleave Biosciences headquartered?
- Cleave Biosciences is headquartered in Burlingame, US.